ISTH-0036

N/A

Report date: 2024/05/06 17:43:51

NME

Base Information

Drug NameISTH-0036

Drug Alias NameISTH-0036

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionTransforming growth factor beta 2 inhibitorsRNA interference

TargetsTransforming growth factor beta 2

Therapy Area/IndicationsDiabetic macular oedemaWet age-related macular degenerationGlaucoma, Open-Angle

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDiabetic macular oedemaWet age-related macular degeneration

Inactive IndicationsGlaucoma, Open-Angle

ATC CodeN/A